| cellular process (GO:0009987) | 0.26 | 10 | CLN6, CLN8, PPT1, CTSD, TPP1, SMPD1, MFSD8, CLN3, CLN5, DNAJC5 |
| single-organism process (GO:0044699) | 0.48 | 10 | GRN, CLN6, CLN8, TPP1, CTSD, PPT1, SMPD1, CLN3, CLN5, DNAJC5 |
| organic substance metabolic process (GO:0071704) | 0.63 | 9 | CTSF, CLN6, CLN8, PPT1, CTSD, TPP1, SMPD1, CLN3, CLN5 |
| biological regulation (GO:0065007) | 0.39 | 9 | GRN, CLN6, CLN8, TPP1, CLN3, PPT1, SMPD1, DNAJC5, CLN5 |
| metabolic process (GO:0008152) | 0.58 | 9 | CTSF, CLN6, CLN8, TPP1, CTSD, PPT1, SMPD1, CLN3, CLN5 |
| primary metabolic process (GO:0044238) | 0.69 | 9 | CTSF, CLN6, CLN8, TPP1, CTSD, PPT1, SMPD1, CLN3, CLN5 |
| single-organism metabolic process (GO:0044710) | 1.63 | 8 | CLN6, CLN8, TPP1, CTSD, PPT1, SMPD1, CLN3, CLN5 |
| protein metabolic process (GO:0019538) | 1.45 | 8 | CTSF, CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
| organic substance catabolic process (GO:1901575) | 2.45 | 8 | CLN3, CLN6, CLN8, TPP1, SMPD1, PPT1, CTSD, CLN5 |
| regulation of cellular process (GO:0050794) | 0.5 | 8 | CLN6, GRN, CLN8, TPP1, CLN3, PPT1, SMPD1, DNAJC5 |
| single-organism cellular process (GO:0044763) | 0.65 | 8 | CLN6, CLN8, TPP1, CLN3, PPT1, SMPD1, CLN5, DNAJC5 |
| macromolecule metabolic process (GO:0043170) | 0.83 | 8 | CTSF, CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
| catabolic process (GO:0009056) | 2.38 | 8 | CLN3, CLN6, CLN8, TPP1, SMPD1, PPT1, CTSD, CLN5 |
| regulation of biological process (GO:0050789) | 0.45 | 8 | CLN6, GRN, CLN8, TPP1, CLN3, PPT1, SMPD1, DNAJC5 |
| organelle organization (GO:0006996) | 2.02 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
| vacuole organization (GO:0007033) | 4.67 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
| multicellular organismal process (GO:0032501) | 1.45 | 7 | CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
| organonitrogen compound metabolic process (GO:1901564) | 2.32 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, SMPD1, CLN5 |
| cellular metabolic process (GO:0044237) | 0.69 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, SMPD1, CLN5 |
| cellular component organization (GO:0016043) | 1.24 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 7 | CLN6, CLN8, TPP1, SMPD1, PPT1, CLN3, CLN5 |
| protein catabolic process (GO:0030163) | 3.93 | 7 | CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
| lysosome organization (GO:0007040) | 6.02 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
| regulation of biological quality (GO:0065008) | 1.68 | 7 | CLN6, CLN8, PPT1, CLN3, TPP1, DNAJC5, CLN5 |
| macromolecule catabolic process (GO:0009057) | 3.0 | 7 | CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
| lytic vacuole organization (GO:0080171) | 6.02 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
| lipid metabolic process (GO:0006629) | 2.68 | 6 | CLN6, CLN8, TPP1, SMPD1, PPT1, CLN3 |
| cellular amide metabolic process (GO:0043603) | 3.23 | 6 | CLN6, CLN8, SMPD1, TPP1, CLN3, CLN5 |
| neurological system process (GO:0050877) | 2.64 | 6 | CLN6, CLN8, TPP1, CLN3, PPT1, CLN5 |
| transport (GO:0006810) | 1.51 | 6 | GRN, CLN8, CLN3, PPT1, MFSD8, DNAJC5 |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 6 | CLN6, CLN8, SMPD1, TPP1, CLN3, CLN5 |
| establishment of localization (GO:0051234) | 1.48 | 6 | GRN, CLN8, CLN3, PPT1, MFSD8, DNAJC5 |
| localization (GO:0051179) | 1.4 | 6 | GRN, CLN8, CLN3, PPT1, MFSD8, DNAJC5 |
| system process (GO:0003008) | 2.3 | 6 | CLN6, CLN8, TPP1, CLN3, PPT1, CLN5 |
| developmental process (GO:0032502) | 1.36 | 5 | CLN8, PPT1, TPP1, CLN5, SMPD1 |
| cellular catabolic process (GO:0044248) | 2.62 | 5 | CLN8, PPT1, CLN6, TPP1, SMPD1 |
| membrane lipid metabolic process (GO:0006643) | 4.51 | 5 | CLN8, PPT1, SMPD1, CLN6, CLN3 |
| establishment of localization in cell (GO:0051649) | 2.47 | 5 | CLN8, PPT1, CLN3, DNAJC5, GRN |
| response to stimulus (GO:0050896) | 1.22 | 5 | CLN8, PPT1, SMPD1, TPP1, GRN |
| anatomical structure development (GO:0048856) | 1.58 | 5 | CLN8, PPT1, TPP1, CLN5, SMPD1 |
| homeostatic process (GO:0042592) | 2.61 | 5 | PPT1, CLN5, TPP1, CLN3, CLN6 |
| regulation of programmed cell death (GO:0043067) | 2.49 | 5 | CLN8, PPT1, SMPD1, DNAJC5, CLN3 |
| proteolysis (GO:0006508) | 2.73 | 5 | TPP1, CLN3, CLN5, CTSD, CTSF |
| negative regulation of biological process (GO:0048519) | 1.33 | 5 | CLN8, PPT1, CLN3, DNAJC5, SMPD1 |
| cellular lipid metabolic process (GO:0044255) | 2.92 | 5 | CLN8, PPT1, SMPD1, CLN3, CLN6 |
| regulation of cell death (GO:0010941) | 2.43 | 5 | CLN8, PPT1, SMPD1, DNAJC5, CLN3 |
| regulation of apoptotic process (GO:0042981) | 2.5 | 5 | CLN8, PPT1, CLN3, DNAJC5, SMPD1 |
| sphingolipid metabolic process (GO:0006665) | 4.79 | 5 | PPT1, CLN8, CLN3, SMPD1, CLN6 |
| negative regulation of cellular process (GO:0048523) | 1.41 | 5 | CLN8, PPT1, SMPD1, DNAJC5, CLN3 |
| regulation of lysosomal lumen pH (GO:0035751) | 7.65 | 4 | PPT1, CLN5, CLN3, CLN6 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 4 | CLN8, SMPD1, CLN3, CLN6 |
| regulation of metabolic process (GO:0019222) | 1.02 | 4 | CLN8, SMPD1, CLN3, CLN6 |
| ion homeostasis (GO:0050801) | 3.42 | 4 | PPT1, CLN6, CLN5, CLN3 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 4 | CLN8, SMPD1, CLN3, CLN6 |
| behavior (GO:0007610) | 3.47 | 4 | CLN8, PPT1, CLN3, GRN |
| inorganic ion homeostasis (GO:0098771) | 3.43 | 4 | PPT1, CLN5, CLN3, CLN6 |
| signal transduction (GO:0007165) | 1.28 | 4 | TPP1, CLN3, SMPD1, GRN |
| regulation of intracellular pH (GO:0051453) | 5.44 | 4 | PPT1, CLN5, CLN3, CLN6 |
| intracellular pH reduction (GO:0051452) | 6.09 | 4 | PPT1, CLN6, CLN5, CLN3 |
| regulation of cellular pH (GO:0030641) | 5.41 | 4 | PPT1, CLN6, CLN5, CLN3 |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 4 | CLN8, PPT1, CLN5, CLN6 |
| regulation of pH (GO:0006885) | 5.24 | 4 | PPT1, CLN6, CLN5, CLN3 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 4 | CLN8, SMPD1, CLN3, CLN6 |
| negative regulation of apoptotic process (GO:0043066) | 3.04 | 4 | PPT1, DNAJC5, CLN8, CLN3 |
| positive regulation of biological process (GO:0048518) | 1.2 | 4 | PPT1, SMPD1, CLN6, GRN |
| regulation of neurotransmitter levels (GO:0001505) | 4.77 | 4 | CLN8, PPT1, DNAJC5, CLN3 |
| cellular homeostasis (GO:0019725) | 3.23 | 4 | PPT1, CLN5, CLN3, CLN6 |
| pH reduction (GO:0045851) | 6.07 | 4 | PPT1, CLN6, CLN5, CLN3 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 4 | CLN8, SMPD1, CLN3, CLN6 |
| negative regulation of cell death (GO:0060548) | 2.95 | 4 | CLN8, DNAJC5, PPT1, CLN3 |
| visual perception (GO:0007601) | 4.41 | 4 | CLN8, CLN5, PPT1, CLN6 |
| sensory perception (GO:0007600) | 2.93 | 4 | CLN8, PPT1, CLN5, CLN6 |
| cellular ion homeostasis (GO:0006873) | 3.57 | 4 | PPT1, CLN6, CLN5, CLN3 |
| sensory perception of light stimulus (GO:0050953) | 4.4 | 4 | CLN8, PPT1, CLN5, CLN6 |
| cellular monovalent inorganic cation homeostasis (GO:0030004) | 5.19 | 4 | PPT1, CLN5, CLN3, CLN6 |
| single-organism transport (GO:0044765) | 2.18 | 4 | PPT1, DNAJC5, CLN8, CLN3 |
| monovalent inorganic cation homeostasis (GO:0055067) | 4.93 | 4 | PPT1, CLN5, CLN3, CLN6 |
| cellular cation homeostasis (GO:0030003) | 3.6 | 4 | PPT1, CLN6, CLN5, CLN3 |
| cation homeostasis (GO:0055080) | 3.46 | 4 | PPT1, CLN5, CLN3, CLN6 |
| cellular chemical homeostasis (GO:0055082) | 3.4 | 4 | PPT1, CLN5, CLN3, CLN6 |
| single-organism localization (GO:1902578) | 2.09 | 4 | PPT1, DNAJC5, CLN8, CLN3 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 4 | CLN8, CLN6, SMPD1, CLN3 |
| vesicle-mediated transport (GO:0016192) | 2.72 | 4 | PPT1, DNAJC5, CLN3, GRN |
| single-multicellular organism process (GO:0044707) | 1.78 | 4 | CLN8, PPT1, CLN3, CTSD |
| vacuolar acidification (GO:0007035) | 7.02 | 4 | PPT1, CLN5, CLN3, CLN6 |
| negative regulation of programmed cell death (GO:0043069) | 3.02 | 4 | CLN8, PPT1, DNAJC5, CLN3 |
| nervous system development (GO:0007399) | 3.53 | 4 | CLN8, PPT1, TPP1, SMPD1 |
| chemical homeostasis (GO:0048878) | 2.97 | 4 | PPT1, CLN6, CLN5, CLN3 |
| cellular developmental process (GO:0048869) | 1.82 | 4 | CLN8, PPT1, TPP1, CLN5 |
| system development (GO:0048731) | 2.92 | 4 | CLN8, TPP1, PPT1, SMPD1 |
| positive regulation of cellular process (GO:0048522) | 1.3 | 4 | PPT1, SMPD1, CLN6, GRN |
| ceramide metabolic process (GO:0006672) | 5.41 | 4 | CLN8, CLN6, CLN3, SMPD1 |
| lysosomal lumen acidification (GO:0007042) | 8.12 | 4 | PPT1, CLN5, CLN3, CLN6 |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 3 | CLN8, SMPD1, CLN3 |
| cell differentiation (GO:0030154) | 2.14 | 3 | CLN8, TPP1, CLN5 |
| learning (GO:0007612) | 4.85 | 3 | PPT1, CLN8, CLN3 |
| learning or memory (GO:0007611) | 4.33 | 3 | PPT1, CLN8, CLN3 |
| cellular biosynthetic process (GO:0044249) | 1.37 | 3 | PPT1, CLN8, SMPD1 |
| regulation of neuron apoptotic process (GO:0043523) | 4.47 | 3 | PPT1, DNAJC5, CLN3 |
| negative regulation of neuron apoptotic process (GO:0043524) | 4.82 | 3 | PPT1, DNAJC5, CLN3 |
| small molecule metabolic process (GO:0044281) | 2.38 | 3 | CLN8, CLN3, CLN6 |
| neuromuscular process (GO:0050905) | 5.27 | 3 | TPP1, CLN8, CLN3 |
| single-organism catabolic process (GO:0044712) | 3.21 | 3 | PPT1, SMPD1, CTSD |
| cellular protein metabolic process (GO:0044267) | 1.63 | 3 | CLN8, PPT1, CLN5 |
| negative regulation of protein metabolic process (GO:0051248) | 2.82 | 3 | CLN8, SMPD1, CLN3 |
| cellular macromolecule catabolic process (GO:0044265) | 3.19 | 3 | PPT1, CLN8, CLN6 |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 3 | CLN8, CLN3, SMPD1 |
| neuromuscular process controlling balance (GO:0050885) | 5.88 | 3 | TPP1, CLN8, CLN3 |
| glycosphingolipid metabolic process (GO:0006687) | 5.49 | 3 | SMPD1, CLN3, CLN6 |
| organic substance transport (GO:0071702) | 2.15 | 3 | PPT1, CLN8, CLN3 |
| regulation of molecular function (GO:0065009) | 1.78 | 3 | PPT1, CLN3, SMPD1 |
| glycolipid metabolic process (GO:0006664) | 5.01 | 3 | CLN3, SMPD1, CLN6 |
| liposaccharide metabolic process (GO:1903509) | 4.98 | 3 | CLN3, SMPD1, CLN6 |
| phospholipid metabolic process (GO:0006644) | 3.88 | 3 | CLN8, SMPD1, CLN3 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 3 | CLN8, CLN3, SMPD1 |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 3 | PPT1, CLN8, SMPD1 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 3 | PPT1, CLN3, SMPD1 |
| biosynthetic process (GO:0009058) | 1.32 | 3 | PPT1, CLN8, SMPD1 |
| associative learning (GO:0008306) | 5.44 | 3 | PPT1, CLN8, CLN3 |
| regulation of proteolysis (GO:0030162) | 3.2 | 3 | CLN8, CLN3, CLN6 |
| neurotransmitter transport (GO:0006836) | 5.07 | 3 | CLN8, PPT1, DNAJC5 |
| regulation of neuron death (GO:1901214) | 4.19 | 3 | DNAJC5, PPT1, CLN3 |
| negative regulation of neuron death (GO:1901215) | 4.57 | 3 | DNAJC5, PPT1, CLN3 |
| negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 3 | CLN8, CLN3, SMPD1 |
| endocytosis (GO:0006897) | 3.69 | 3 | PPT1, CLN3, GRN |
| organonitrogen compound catabolic process (GO:1901565) | 3.91 | 3 | TPP1, PPT1, SMPD1 |
| membrane organization (GO:0061024) | 3.04 | 3 | PPT1, CLN8, CLN3 |
| single-organism behavior (GO:0044708) | 3.79 | 3 | PPT1, CLN8, CLN3 |
| carbohydrate derivative metabolic process (GO:1901135) | 3.07 | 3 | CLN6, SMPD1, CLN3 |
| receptor-mediated endocytosis (GO:0006898) | 4.31 | 3 | PPT1, CLN3, GRN |
| cognition (GO:0050890) | 4.2 | 3 | PPT1, CLN8, CLN3 |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 3 | CLN8, CLN3, SMPD1 |
| phosphorus metabolic process (GO:0006793) | 2.15 | 3 | CLN8, SMPD1, CLN3 |
| organophosphate metabolic process (GO:0019637) | 3.04 | 3 | CLN8, SMPD1, CLN3 |
| signal release from synapse (GO:0099643) | 5.16 | 2 | DNAJC5, PPT1 |
| steroid metabolic process (GO:0008202) | 4.32 | 2 | CLN8, CLN6 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 2 | SMPD1, CLN6 |
| sphingolipid catabolic process (GO:0030149) | 6.64 | 2 | PPT1, SMPD1 |
| vesicle localization (GO:0051648) | 4.85 | 2 | DNAJC5, CLN3 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | SMPD1, CLN6 |
| (GO:0099003) | 5.51 | 2 | DNAJC5, GRN |
| negative regulation of proteolysis (GO:0045861) | 3.98 | 2 | CLN8, CLN3 |
| antigen processing and presentation of peptide antigen via MHC class II (GO:0002495) | 5.19 | 2 | CTSF, CTSD |
| regulation of cellular component organization (GO:0051128) | 2.01 | 2 | PPT1, GRN |
| protein processing (GO:0016485) | 4.62 | 2 | CLN5, CLN3 |
| anion transport (GO:0006820) | 3.71 | 2 | CLN8, CLN3 |
| antigen processing and presentation of peptide antigen (GO:0048002) | 4.56 | 2 | CTSF, CTSD |
| cellular lipid catabolic process (GO:0044242) | 4.73 | 2 | PPT1, SMPD1 |
| establishment of organelle localization (GO:0051656) | 4.15 | 2 | DNAJC5, CLN3 |
| establishment of vesicle localization (GO:0051650) | 4.91 | 2 | DNAJC5, CLN3 |
| response to organic cyclic compound (GO:0014070) | 3.07 | 2 | SMPD1, GRN |
| immune system process (GO:0002376) | 2.29 | 2 | CTSF, CTSD |
| cholesterol metabolic process (GO:0008203) | 5.03 | 2 | CLN8, CLN6 |
| single-organism biosynthetic process (GO:0044711) | 2.8 | 2 | CLN8, SMPD1 |
| negative regulation of catalytic activity (GO:0043086) | 3.0 | 2 | CLN3, SMPD1 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | SMPD1, CLN6 |
| ammonium ion metabolic process (GO:0097164) | 5.26 | 2 | SMPD1, CLN3 |
| positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | SMPD1, CLN6 |
| amide biosynthetic process (GO:0043604) | 3.6 | 2 | CLN8, SMPD1 |
| adult locomotory behavior (GO:0008344) | 5.3 | 2 | PPT1, CLN8 |
| nitrogen compound transport (GO:0071705) | 3.54 | 2 | CLN8, CLN3 |
| animal organ development (GO:0048513) | 2.53 | 2 | PPT1, CLN5 |
| positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | SMPD1, CLN6 |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | CLN8, CLN6 |
| sphingomyelin metabolic process (GO:0006684) | 7.16 | 2 | SMPD1, CLN3 |
| negative regulation of molecular function (GO:0044092) | 2.74 | 2 | SMPD1, CLN3 |
| membrane lipid catabolic process (GO:0046466) | 6.51 | 2 | PPT1, SMPD1 |
| antigen processing and presentation of exogenous peptide antigen (GO:0002478) | 4.63 | 2 | CTSF, CTSD |
| lipid biosynthetic process (GO:0008610) | 3.49 | 2 | CLN8, SMPD1 |
| carboxylic acid transport (GO:0046942) | 4.28 | 2 | CLN8, CLN3 |
| autophagy (GO:0006914) | 3.82 | 2 | CLN3, CTSD |
| sphingolipid biosynthetic process (GO:0030148) | 5.38 | 2 | CLN8, SMPD1 |
| locomotory behavior (GO:0007626) | 4.53 | 2 | PPT1, CLN8 |
| antigen processing and presentation (GO:0019882) | 4.36 | 2 | CTSF, CTSD |
| sterol metabolic process (GO:0016125) | 4.92 | 2 | CLN8, CLN6 |
| antigen processing and presentation of exogenous antigen (GO:0019884) | 4.59 | 2 | CTSF, CTSD |
| antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) | 5.21 | 2 | CTSF, CTSD |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504) | 5.14 | 2 | CTSF, CTSD |
| amino acid transport (GO:0006865) | 5.29 | 2 | CLN8, CLN3 |
| ion transport (GO:0006811) | 2.66 | 2 | CLN8, CLN3 |
| organic anion transport (GO:0015711) | 4.07 | 2 | CLN8, CLN3 |
| signal release (GO:0023061) | 4.65 | 2 | PPT1, DNAJC5 |
| single-organism developmental process (GO:0044767) | 1.49 | 2 | PPT1, CLN5 |
| secondary alcohol metabolic process (GO:1902652) | 5.0 | 2 | CLN8, CLN6 |
| response to stress (GO:0006950) | 1.8 | 2 | TPP1, CLN8 |
| single-organism membrane organization (GO:0044802) | 3.19 | 2 | PPT1, CLN8 |
| neurotransmitter secretion (GO:0007269) | 5.7 | 2 | PPT1, DNAJC5 |
| membrane lipid biosynthetic process (GO:0046467) | 4.99 | 2 | CLN8, SMPD1 |
| cellular protein catabolic process (GO:0044257) | 6.51 | 2 | PPT1, CLN8 |
| response to chemical (GO:0042221) | 1.98 | 2 | SMPD1, GRN |
| response to organic substance (GO:0010033) | 2.2 | 2 | SMPD1, GRN |
| organelle localization (GO:0051640) | 3.94 | 2 | DNAJC5, CLN3 |
| cellular localization (GO:0051641) | 2.32 | 2 | DNAJC5, CLN3 |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 2 | SMPD1, GRN |
| adult behavior (GO:0030534) | 4.79 | 2 | PPT1, CLN8 |
| secretion (GO:0046903) | 3.38 | 2 | PPT1, DNAJC5 |
| single-organism cellular localization (GO:1902580) | 3.16 | 2 | DNAJC5, CLN3 |
| cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 2 | CLN8, SMPD1 |
| brain development (GO:0007420) | 4.24 | 2 | PPT1, CLN5 |
| organonitrogen compound biosynthetic process (GO:1901566) | 2.85 | 2 | CLN8, SMPD1 |
| secretion by cell (GO:0032940) | 3.59 | 2 | DNAJC5, PPT1 |
| lipid catabolic process (GO:0016042) | 4.21 | 2 | PPT1, SMPD1 |
| alcohol metabolic process (GO:0006066) | 4.2 | 2 | CLN8, CLN6 |
| single-organism organelle organization (GO:1902589) | 2.68 | 2 | CLN8, CLN3 |
| presynaptic process involved in chemical synaptic transmission (GO:0099531) | 4.98 | 2 | DNAJC5, PPT1 |
| peptide metabolic process (GO:0006518) | 3.44 | 2 | TPP1, CLN5 |
| protein maturation (GO:0051604) | 4.48 | 2 | CLN5, CLN3 |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 2 | PPT1, GRN |
| ceramide biosynthetic process (GO:0046513) | 5.94 | 2 | CLN8, SMPD1 |
| organic hydroxy compound metabolic process (GO:1901615) | 3.84 | 2 | CLN8, CLN6 |